Pfizer developed Zyvox (linezolid) as the first oxazolidinone antimicrobial agent. The drug gained its first regulatory approval for the treatment of complicated skin and skin structure infections (cSSSI) in the US market in 2000.
Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!